Form 4: ALHC Officer Sells Shares Under 10b5-1 Plan

Alignment Healthcare's Chief Legal and Admin. Officer, Christopher J. Joyce, sold 10,611 shares of common stock for $20.0349 per share under a pre-arranged 10b5-1 plan.

Summary

• Christopher J. Joyce, Chief Legal and Admin. Officer of Alignment Healthcare, Inc. (ALHC), reported the sale of 10,611 shares of common stock.
• The transaction occurred on January 2, 2026, at a weighted-average price of $20.0349 per share, with prices ranging from $19.46 to $20.35.
• The shares were sold pursuant to a Rule 10b5-1 plan adopted on September 8, 2025.
• Following this transaction, Mr. Joyce beneficially owns 297,088 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: Neutral. The filing reports a pre-planned insider sale, which is a routine disclosure and does not inherently signal strong positive or negative sentiment about the company's immediate prospects. The sale is under a 10b5-1 plan, indicating it was scheduled in advance rather than a reaction to recent events.

Negatives

• An insider sale of 10,611 shares, even if pre-planned, reduces the officer's direct equity stake in the company.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

This filing reports a routine, pre-scheduled insider transaction by a key officer, which is common for personal financial planning and does not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The sale by a key officer could be perceived negatively by some shareholders, though the 10b5-1 plan mitigates this concern as it's a pre-scheduled event. It slightly reduces the alignment of this specific officer's direct equity interest with shareholders.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled insider sale under a Rule 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually indicate a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this disclosure. The sale is not significant enough to materially impact the company's valuation or signal a strong negative sentiment from management.

Keywords

Alignment Healthcare, ALHC, Insider Sale, Form 4, Christopher J. Joyce, 10b5-1 Plan, Officer Transaction, Equity Sale